Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2.32%
operating margin TTM
6.87%
revenue TTM
117.04 Million
revenue per share TTM
4.79$
valuation ratios | |
|---|---|
| pe ratio | -50.16 |
| peg ratio | -0.71 |
| price to book ratio | 2.42 |
| price to sales ratio | 1.13 |
| enterprise value multiple | 7.50 |
| price fair value | 2.42 |
profitability ratios | |
|---|---|
| gross profit margin | 54.66% |
| operating profit margin | 6.87% |
| pretax profit margin | -2.34% |
| net profit margin | -2.32% |
| return on assets | -1.68% |
| return on equity | -4.72% |
| return on capital employed | 7.28% |
liquidity ratios | |
|---|---|
| current ratio | 1.30 |
| quick ratio | 0.64 |
| cash ratio | 0.12 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 234.11 |
| operating cycle | 280.64 |
| days of payables outstanding | 299.46 |
| cash conversion cycle | -18.83 |
| receivables turnover | 7.84 |
| payables turnover | 1.22 |
| inventory turnover | 1.56 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.18 |
| debt equity ratio | 0.55 |
| long term debt to capitalization | 0.33 |
| total debt to capitalization | 0.35 |
| interest coverage | 1.66 |
| cash flow to debt ratio | 0.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.04 |
| cash per share | 0.17 |
| operating cash flow per share | 0.43 |
| free cash flow operating cash flow ratio | -0.09 |
| cash flow coverage ratios | 0.53 |
| short term coverage ratios | 5.79 |
| capital expenditure coverage ratio | 0.92 |
Frequently Asked Questions
When was the last time Medexus Pharmaceuticals Inc. (PNK:MEDXF) reported earnings?
Medexus Pharmaceuticals Inc. (MEDXF) published its most recent earnings results on 31-03-2026.
What is Medexus Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Medexus Pharmaceuticals Inc. (PNK:MEDXF)'s trailing twelve months ROE is -4.72%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Medexus Pharmaceuticals Inc. (MEDXF) currently has a ROA of -1.68%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MEDXF's net profit margin stand at?
MEDXF reported a profit margin of -2.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MEDXF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.30 in the most recent quarter. The quick ratio stood at 0.64, with a Debt/Eq ratio of 0.55.